Vivek N. Iyer

Dr. Vivek N. Iyer is a Professor of Pulmonary Medicine at Mayo Clinic College of Medicine in Rochester, Minnesota, where he serves as Director of both the Mayo Clinic Hereditary Hemorrhagic Telangiectasia (HHT) Center of Excellence and the Mayo Chronic Cough Clinic. With over a decade of specialized experience, he is a national leader in HHT management and chronic cough treatment, seeing thousands of patients annually through these specialized clinics.

• Department of Pulmonary Medicine, Mayo Clinic
• Director, Mayo Clinic HHT Center of Excellence
• Director, Mayo Chronic Cough Clinic
• Specialist in Interstitial Lung Disease, Asthma, and Sarcoidosis

Dr. Iyer's primary research interests focus on Hereditary Hemorrhagic Telangiectasia, chronic cough management, severe asthma, and interstitial lung diseases. He has pioneered the use of bevacizumab and other anti-angiogenic agents for HHT-related bleeding and has been principal investigator for multiple clinical trials exploring novel therapeutics for chronic refractory cough. His work bridges clinical practice with translational research, particularly in vascular biology related to HHT and innovative digital health solutions for pulmonary conditions.

Analysis of Dr. Iyer's recent publications (2022-2025) reveals a strong focus on Hereditary Hemorrhagic Telangiectasia management, with significant contributions to standardizing terminology and treatment protocols. His work increasingly incorporates digital health technologies, particularly voice analysis and AI applications in pulmonology. He maintains an active research program in vascular malformations, cough mechanisms, and novel therapeutic approaches for complex pulmonary conditions.

• Robert I White Jr. MD Young Clinician Award in HHT (2019)
• TOP RATED ABSTRACT Mayo Clinic Quality Conference (2017)
• Critical Care Fellows 'Teacher Of The Year' Award (2015)
• Multiple best poster and research citation awards
• Dean's Honor list during medical school

Dr. Iyer serves as an active mentor and educator, evidenced by multiple teaching awards throughout his career. He has participated in numerous multicenter clinical trials, particularly in HHT management and cough therapeutics. His leadership extends to the Cure HHT Research Network where he serves as Director and on the Annual Meeting Planning Committee. He maintains active collaborations with international researchers in the HHT field.

Dr. Iyer directs specialized clinical programs including the HHT Center of Excellence and Chronic Cough Clinic, which represent multidisciplinary teams of specialists dedicated to complex pulmonary and vascular conditions. His Chronic Cough Clinic is noted as one of the busiest in the country, seeing over 3,000 new patients annually with difficult-to-treat cough.